While net sales grew by 20.4% to Rs 490 crore, a volume growth of 11% was the main takeaway of the results. Naresh H Bahnsali, CEO, finance, strategy & business development, Emami group tells Arindam Majumder that the results were according to expectations and the company plans further acquisitions in near future.
What are your views on the results of this quarter?
Also Read
Apart from these, new launches like Fair and Handsome facewash, Zandu Ultra Power Balm, HE deodrant have also done very well and have contributed around 6% of the domestic turnover.
What about the company’s international business? Are there plans of acquisitions abroad?
Our international business has grown by 33% and that has helped us to achieve a topline growth of 20.4% this quarter. There is focus on evaluating inorganic opportunities. Middle East and SAARC countries are under our focus, we are looking at opportunities which can supplement our presence there
Emami has always been a distributor-based company which has primarily focused on rural markets. Is it changing?
We give equal importance to rural and urban markets. In this quarter, growth has come from rural and urban market.Even, in the urban our presence has increased in modern trade. Our growth from modern trade is around 40% this quarter. We are strenghtening both the positions.
Your annual report said “Emami has extended from a dependence on climatic variations to predictable annuity usage.” Has the company been able to do that?
Though seasons impact the company’s results, round-the-year products like Balm and Fair and Handsome segment has also shown a stellar performance. Round the season products like Balm and Fair and Handsome sales grew by 12% and 16% as compared to 13% and 14% in the previous quarter.
Despite spending on advertisements going up, the results show that you have been able to maintain a good operating margin. Is it due to the price of raw materials prices coming down?
Prices of few raw materials like mentha have gone down and it has increased for few others. But the good EBITDA margin you see is due to our extensive work in cost-improvement techniques. This has resulted in reporting margin expansion. We have also increased the price increase very judiciously. But mind you price rise was normal and according to market force and as it happens every year.
Are there any plans of new launches?
Soon, there would be new launches from the healthcare division. We are also in the initial phase of launching the She Comfort. It has placed in some markets. Commercial campaigning will start soon.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
